Carregant...
PDTM-15. PLX51107, A NOVEL BROMODOMAIN INHIBITOR, WORKS SYNERGISTICALLY WITH AURORA-A KINASE INHIBITOR MLN8327 IN TREATING MYC-AMPLIFIED MEDULLOBLASTOMA
Group 3 medulloblastoma is a malignant childhood brain tumor with the worst prognosis among all subtypes of medulloblastoma. This subgroup has the highest frequency of MYC amplification. BRD4 is a member of the human bromodomain and extraterminal domain (BET) family of proteins and functions through...
Guardat en:
| Publicat a: | Neuro Oncol |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5692800/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.779 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|